Concord medical files 2022 annual report on form 20-f

Beijing , april 19, 2023 /prnewswire/ -- concord medical services holdings limited ("concord medical" or the "company") (nyse: ccm), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in china, today announced that it filed its annual report on form 20-f for the fiscal year ended december 31, 2022 (the "annual report") with the u.s. securities and exchange commission. an electronic copy of the annual report can be accessed on concord medical's investor relations website at http://ir.ccm.cn and on the sec's website at www.sec.gov.
CCM Ratings Summary
CCM Quant Ranking